- Home
- SLNO vs PGNY Comparison
SLNO vs PGNY Comparison
Compare SLNO & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLNO | PGNY |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2014 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SLNO | PGNY |
|---|---|---|
| Price | $42.23 | $24.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $110.90 | $27.67 |
| AVG Volume (30 Days) | ★ 1.6M | 1.4M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.96 |
| EPS | N/A | ★ 0.62 |
| Revenue | $98,675,000.00 | ★ $1,268,689,000.00 |
| Revenue This Year | N/A | $11.63 |
| Revenue Next Year | $155.86 | $9.52 |
| P/E Ratio | ★ N/A | $39.72 |
| Revenue Growth | N/A | ★ 11.41 |
| 52 Week Low | $39.43 | $17.98 |
| 52 Week High | $90.32 | $28.75 |
Technical Indicators
Market Signals| Indicator | SLNO | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 36.70 | 43.54 |
| Support Level | $39.43 | $26.93 |
| Resistance Level | $50.88 | $28.75 |
| Average True Range (ATR) | 2.79 | 1.16 |
| MACD | -0.24 | -0.31 |
| Stochastic Oscillator | 26.46 | 9.68 |
Price Performance
Historical ComparisonAbout SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About PGNY Progyny Inc.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.